New biomarker-guided strategy has potential for liver cancer treatment

A study at The University of Texas MD Anderson Cancer Center discovered a cellular pathway tied to cancer that may be beneficial in reducing side effects and extending duration of immunotherapy in some patients with hepatocellular carcinoma, the most common form of liver cancer.

source https://www.lifetechnology.com/blogs/life-technology-news-blog/new-biomarker-guided-strategy-has-potential-for-liver-cancer-treatment